MiR‐146a demonstrated a significant reduction in the degradation of IκBα and the expression of phosphorylated‐p65 in AP mice, suggesting its potential to inhibit the NF‐κB axis‐mediated immune response. The gene discussed is NFKB1; the disease is alkaline phosphatase measurement.